Multi-chamber injector for sequential delivery of
By designing a multi-chamber syringe, the sequential discharge of the first and second fluids is achieved using sliding and rotating stops, the problems of contamination and blockage of the vascular access device are solved, simplifying drug administration procedures and reducing the risk of infection.
Patent Information
- Application Number
- CN202380032955.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2022-04-04
- Filing Date
- 2023-03-31
- Publication Date
- 2024-11-15
AI Technical Summary
Existing vascular access devices are easily contaminated and blocked during use, resulting in an increased risk of infection, and traditional syringes need to be frequently connected and disconnected, increasing the risk of contamination and infection.
A multi-chamber syringe is designed, including a cylinder, a first stopper and a second stopper, and the sequential discharge of the first fluid and the second fluid is achieved through sliding and rotating, reducing the number of connections and disconnections, and reducing the Pollution risk.
简化了药物施用程序,减少了对血管通路装置的污染和感染风险,提高了流体输送的效率和安全性。
Smart Images

Figure CN118973638A_ABST
Abstract
Description
[0001] CROSS-REFERENCE TO RELATED APPLICATIONS
[0002] This application claims priority to U.S. Provisional Application No. 63 / 327,185, filed on April 4, 2022, entitled “Multi-Chamber Syringe for Sequential Delivery of Fluids and Methods of Use,” the entire disclosure of which is incorporated herein by reference in its entirety.
[0003] Background of the Invention
[0004] Field of the Invention
[0005] The present disclosure relates generally to syringes for expelling multiple fluids, and more particularly to a syringe for sequentially expelling a first fluid (eg, a medical fluid) followed by a second fluid (eg, a flushing solution).
[0006] Description of the Prior Art
[0007] A vascular access device (VAD) is a commonly used medical device that may include an intravenous (IV) catheter (e.g., a peripheral catheter or a central venous catheter). A VAD may become contaminated, blocked by blood clots, and / or may spread infection if not properly maintained or if exposed to a non-sterile environment. Many medical institutions implement aseptic practices and protocols to ensure that the VAD is used correctly and does not become sealed or infected. These protocols typically include disinfecting the VAD and flushing the catheter with a flushing solution. Specifically, VAD practice standards typically recommend performing a flushing procedure after catheter placement, before fluid infusion, before and after medication administration, before and after blood sampling, before and after transfusion, and / or before and after parenteral nutrition administration.
[0008] These flushing procedures are designed to confirm catheter patency, avoid medication incompatibilities, ensure that a complete medication dose is administered to the patient, prevent thrombosis, and minimize the risk of bloodstream infection due to VAD contamination. In addition, flushing prevents deposits of blood, blood residue, and IV medications from accumulating within the catheter or other VAD device. This accumulation may result in partial or complete blockage of the fluid path in the catheter system, which may require the practitioner to perform certain expensive and potentially dangerous procedures to clear the affected catheter, or may require the practitioner to exchange the blocked catheter for a new one. Often, this blockage results in an interruption in treatment, which may compromise patient care. The accumulation of residue within the catheter may also increase the risk of infection.
[0009] During the administration of a drug or another medical fluid, the catheter or VAD is typically flushed before and after the fluid is delivered to the VAD from a syringe or from another drug delivery device. In some cases, a syringe assembly pre-filled with various fluids (referred to herein as flushing solutions) can be used to flush the catheter. The size of the pre-filled syringe for flushing the catheter varies, for example, depending on the size and length of the catheter. Typically, the pre-filled syringe for flushing the catheter or IV line contains a flushing solution having a volume of about 1 mL, 3 mL, 5 mL, or 10 mL. Many different syringes commercially available from different manufacturers can be used to provide flushing solutions through the patient's catheter or IV line, including, for example, the BD PosiFlush from Becton, Dickinson and Company, and the BD PosiFlush from Becton, Dickinson and Company. TM Pre-filled saline syringe.
[0010] To perform a flushing procedure, the practitioner connects a prefilled flushing syringe to the VAD and advances a plunger rod in the barrel of the prefilled syringe so that the flushing solution is discharged to the VAD through the nozzle or fluid port of the prefilled syringe. After flushing, the prefilled syringe is disconnected from the VAD so that the practitioner can administer a dose of a medical fluid. Traditionally, medical fluids are contained in vials and drawn into a separate syringe that is connected to the VAD after being filled with the medical fluid. The medical fluid is then injected into the VAD by advancing the plunger rod through the syringe containing the medical fluid. After the medical fluid is injected into the VAD, the syringe is disconnected from the VAD and the VAD is flushed using a second prefilled flushing syringe. Flushing the VAD after administering the medical fluid confirms the patency of the catheter and advances the remaining medical fluid in the catheter toward the patient to ensure that the full dose of the medical fluid is delivered to the patient.
[0011] Connecting or disconnecting a syringe or other device to a VAD introduces portions of the VAD to an unsterile external environment, which increases the likelihood that the VAD will become contaminated and / or will become a source of bloodstream infection. In order to reduce the risk of bloodstream infection and ensure the proper use and maintenance of the VAD, standards of practice require that any fluid ports or connectors of the VAD be disinfected and cleaned each time a new syringe is connected to the VAD. Thus, reducing the number of syringes that must be connected to the VAD during a drug delivery procedure simplifies drug administration by reducing the number of times portions of the VAD must be disinfected and cleaned. Reducing the number of syringes or other fluid delivery devices used during a procedure also reduces the chances that portions of the VAD will become contaminated, thereby reducing the risk of bloodstream infection. The syringes and methods of the present disclosure provide a simplified drug administration procedure by reducing the number of syringes used during such procedures, thereby reducing the risk of contamination and bloodstream infection. Summary of the invention
[0012] According to one aspect of the present disclosure, a multi-chamber syringe for sequentially discharging at least a first fluid and a subsequent second fluid comprises a barrel, a first stopper and a second stopper. The barrel comprises a proximal end, a distal end, and a sidewall extending between the proximal end and the distal end of the barrel, the distal end having a fluid port for discharging the first fluid and the second fluid from the barrel. A first stopper comprising at least one channel is slidably positioned in the barrel so that a first chamber configured to accommodate the first fluid is disposed between the distal end of the barrel and the first stopper. The second stopper is slidably positioned in the barrel near the first stopper so that a second chamber configured to accommodate the second fluid is disposed between the first stopper and the second stopper. The first stopper establishes fluid communication between the second chamber and the first chamber through the at least one channel of the first stopper relative to the rotation of the barrel of the syringe.
[0013] According to another aspect of the present disclosure, a prefilled flushing syringe comprises any of the previously described multi-chamber syringes and a predetermined volume of the second fluid disposed in a second chamber of the prefilled syringe. The prefilled syringe is provided with a first chamber that is fluidically isolated from the second chamber, such that the predetermined volume of the second fluid is contained in the second chamber of the prefilled syringe.
[0014] According to another aspect of the present disclosure, a method for sequentially discharging fluids from a multi-chamber syringe includes the steps of moving a first stopper and a second stopper of any of the previously described syringes in a distal direction through a barrel, thereby discharging a first fluid from the barrel through a fluid port of the barrel. The method also includes rotating the first stopper to establish fluid communication between the second chamber and the first chamber; and moving the second stopper through the barrel toward the first stopper in the distal direction, thereby causing the second fluid to pass from the second chamber through at least one channel of the first stopper, the first chamber, and the fluid port of the barrel.
[0015] Non-limiting illustrative examples of embodiments of the present disclosure will now be described in the following numbered items.
[0016] Article 1: A multi-chamber syringe for sequentially discharging at least a first fluid and subsequently a second fluid, the syringe comprising: a barrel, a first stopper, and a second stopper, the barrel comprising a proximal end, a distal end, and a sidewall extending between the proximal end and the distal end of the barrel, the distal end comprising a fluid port for discharging the first fluid and the second fluid from the barrel; the first stopper comprising at least one channel, the first stopper being slidably positioned in the barrel, wherein a first chamber is provided between the distal end of the barrel and the first stopper, the first chamber being configured to accommodate the first fluid; the second stopper being slidably positioned in the barrel proximate to the first stopper, wherein a second chamber is provided between the first stopper and the second stopper, the second chamber being configured to accommodate the second fluid, wherein rotation of the first stopper relative to the barrel of the syringe establishes fluid communication between the second chamber and the first chamber through the at least one channel of the first stopper.
[0017] Clause 2: The syringe of Clause 1, wherein movement of the first stopper and the second stopper in a proximal direction through the barrel causes fluid to be drawn into the first chamber through the fluid port of the barrel.
[0018] Clause 3: A syringe as described in Clause 1 or Clause 2, wherein, in a filling position in which the first fluid is in the first chamber and the second fluid is in the second chamber, the first stop is separated from the second stop and the second chamber is not in fluid communication with the first chamber.
[0019] Clause 4: The syringe of Clause 3, wherein advancing the first stop and the second stop in a distal direction from the filling position to the intermediate position expel the first fluid from the first chamber through the barrel through the fluid port of the barrel.
[0020] Clause 5: The syringe of Clause 4, wherein, in the intermediate position, the first stop is in a distal-most position within the barrel of the syringe and all or substantially all of the first fluid is expelled from the first chamber.
[0021] Article 6: A syringe as described in Article 4 or Article 5, wherein, with these stops in the intermediate position, rotating the first stop establishes fluid communication between the second chamber and the first chamber through at least one fluid channel of the first stop.
[0022] Article 7: A syringe as described in Article 6, wherein, when the second chamber is fluidly connected to the first chamber, the second stop member moves axially through the barrel toward the first stop member to move the second fluid from the second chamber through the at least one channel of the first stop member, the first chamber and the fluid port of the barrel, thereby expelling the second fluid from the barrel.
[0023] Article 8: A syringe as described in any one of Articles 1 to 7, wherein the barrel comprises at least one of polyester, polycarbonate, polypropylene, polyethylene, polyethylene terephthalate or acrylonitrile butadiene styrene.
[0024] Clause 9: The syringe of any one of Clauses 1 to 8, wherein the first stopper and / or the second stopper comprises a thermoplastic elastomer.
[0025] Article 10: A syringe as described in Article 9, wherein the first stopper and / or the second stopper includes a proximal end, a distal end, an outer surface extending between the proximal end and the distal end, and at least one annular rib protruding from the outer surface, and the at least one annular rib seals against the inner surface of the side wall of the barrel.
[0026] Article 11: A syringe as described in any one of Articles 1 to 10, wherein the barrel includes at least one widened portion, wherein the radial distance between the inner surface of the side wall of the barrel and the central axis of the barrel in the at least one widened portion is greater than the radial distance between the inner surface of the side wall and the central axis of the barrel in other parts of the barrel.
[0027] Item 12: The syringe of Item 11, wherein the at least one widened portion has an arc width of from 45 degrees to 70 degrees around the central axis of the barrel.
[0028] Clause 13: The syringe of Clause 12, wherein the at least one widened portion of the barrel comprises a first widened portion on one side of the barrel and a second widened portion on an opposite side of the barrel such that the barrel is vertically symmetrical.
[0029] Clause 14: A syringe as described in any one of Clauses 11 to 13, wherein the at least one channel through the first stop member includes an inlet and an outlet, and wherein fluid flow through the at least one channel occurs only when the outlet of the at least one channel is located in the at least one widened portion of the barrel.
[0030] Article 15: A syringe as described in any one of Articles 11 to 14, wherein when the outlet of the at least one channel is not in the at least one widened portion of the barrel, the second chamber and the first chamber are not fluidly connected through the at least one channel of the stopper.
[0031] Article 16: A syringe as described in any one of Articles 1 to 15, wherein the at least one channel of the first stopper includes a first cutout section located on one side of the stopper and a second cutout section located on a side of the first stopper opposite to the first cutout section, so that the first stopper is vertically symmetrical.
[0032] Clause 17: In the syringe of any one of Clauses 1 to 15, the at least one channel comprises at least one closed passage extending from an inlet on the proximal end of the first stopper to an outlet on a side surface of the first stopper.
[0033] Article 18: The syringe as described in Article 17, wherein the at least one closed passage includes a first closed passage located on one side of the first stopper and a second closed passage located radially on a side of the first stopper opposite to the first closed passage, so that the first stopper is vertically symmetrical.
[0034] Clause 19: The syringe of any one of Clauses 1 to 18, wherein the first stop member comprises a recessed groove on the distal end of the first stop member, the recessed groove being positioned to allow fluid to flow through the first stop member to the fluid port of the barrel.
[0035] Clause 20: The syringe of any one of Clauses 1 to 19, further comprising at least one guide member fixed to the first stopper for rotating the first stopper relative to the barrel.
[0036] Clause 21: The syringe of Clause 20, wherein the distal portion of the guide member is received within the cavity of the first stop, and wherein the guide member includes at least one axially extending ridge that engages the axial slot of the cavity to secure the guide member to the first stop.
[0037] Article 22: The syringe of Article 20 or Article 21, wherein the second stop includes a through hole, and wherein the at least one guide member extends through the through hole to allow the second stop to slide along the guide member as the second stop moves in a distal direction through the barrel.
[0038] Clause 23: The syringe of any one of Clauses 20 to 22, further comprising a plunger rod connected to the second stopper for moving the second stopper and / or the first stopper through the barrel.
[0039] Clause 24: The syringe of Clause 23, further comprising a removable plunger cap engaged between the plunger rod and the barrel to prevent movement of the plunger rod until the removable plunger cap is removed from the syringe.
[0040] Clause 25: The syringe of Clause 23 or Clause 24, wherein the distal end of the plunger rod engages in the annular cavity on the proximal end of the second stopper.
[0041] Clause 26: The syringe of any one of Clauses 23 to 25, wherein the plunger rod comprises an elongated recess that receives the guide member as the second stop moves through the barrel in a distal direction toward the first stop.
[0042] Clause 27: The syringe of Clause 26, wherein the plunger rod comprises an inwardly projecting tab that engages the at least one guide member such that rotation of the plunger rod rotates the at least one guide member and the first stop.
[0043] Clause 28: The syringe of any one of Clauses 23 to 27, wherein the barrel comprises at least one rotation limiter engaged with the plunger rod to prevent rotation of the plunger rod, the stops and the at least one guide member unless the first stop is in a distal-most position in the barrel.
[0044] Article 29: A prefilled flushing syringe, comprising: the syringe described in any one of Articles 1 to 28; and a predetermined volume of the second fluid disposed in the second chamber of the prefilled syringe, wherein the prefilled syringe is provided with the first chamber, the first chamber is isolated from the second chamber fluid, so that the predetermined volume of the second fluid is contained in the second chamber of the prefilled syringe.
[0045] Article 30. The prefilled syringe of Article 29, wherein the second fluid comprises saline and / or a heparin flush solution.
[0046] Clause 31: The prefilled syringe of Clause 29 or Clause 30, wherein the syringe further comprises a plunger rod connected to the second stopper for moving the second stopper and / or the first stopper through the barrel.
[0047] Article 32: A prefilled syringe as described in Article 31, further comprising a removable plunger cap engaged between the plunger rod and the barrel of the syringe to prevent movement of the plunger rod until the cap is removed, thereby maintaining fluid isolation between the first chamber and the second chamber until the plunger cap is removed.
[0048] Article 33: A method for sequentially expelling fluid from a syringe as described in any one of Articles 1 to 28, the method comprising: moving the first stop and the second stop of the syringe as described in any one of Articles 1 to 28 in a distal direction through the barrel, thereby expelling the first fluid from the barrel through the fluid port of the barrel; rotating the first stop to establish fluid communication between the second chamber and the first chamber; and moving the second stop through the barrel toward the first stop in the distal direction, thereby allowing the second fluid to pass from the second chamber through the at least one channel of the first stop, the first chamber, and the fluid port of the barrel.
[0049] Clause 34: The method of Clause 33, wherein the syringe is configured to be partially pre-filled, containing a predetermined volume of the second fluid in the second chamber.
[0050] Clause 35: The method of Clause 34, further comprising: withdrawing the first fluid into the first chamber of the barrel of the partially prefilled syringe by moving the stops in a proximal direction through the barrel.
[0051] Article 36: A method as described in Article 35, wherein drawing the first fluid into the first chamber includes: attaching a needle to the fluid port of the barrel of the syringe, inserting the needle into a fluid container, and drawing the first fluid from the fluid container into the first chamber of the syringe.
[0052] Article 37: A method as described in any of Articles 33 to 36, further comprising: attaching at least one patient line to the fluid port of the syringe before moving the stoppers in the distal direction through the barrel, wherein the fluid discharged from the syringe is delivered to the patient through the at least one patient line.
[0053] Clause 38: The method of any one of Clauses 33 to 37, wherein the first fluid comprises a therapeutic agent and the second fluid comprises a flushing solution, such as a saline solution and / or a heparin lock flushing solution. BRIEF DESCRIPTION OF THE DRAWINGS
[0054] Figure 1A is a perspective view of a multi-chamber syringe according to one aspect of the present disclosure.
[0055] Figure 1B yes Figure 1A Exploded perspective view of a multi-chamber syringe.
[0056] Figure 2A Is in the initial or partially filled position Figure 1A Side view of a multi-chamber syringe.
[0057] Figure 2B is in the filling position Figure 1A Cross-sectional view of a multi-chamber syringe.
[0058] Figure 2C is an intermediate position with a filled second chamber and an empty first chamber Figure 1A Cross-sectional view of a multi-chamber syringe.
[0059] Figure 2D The intermediate position is after the first stopper is rotated to establish fluid communication between the second chamber and the first chamber. Figure 1A Cross-sectional view of a multi-chamber syringe.
[0060] Figure 2E is the final position after the first fluid and the second fluid are expelled from the syringe. Figure 1A Cross-sectional view of a multi-chamber syringe.
[0061] Figure 3A According to one aspect of the present disclosure Figure 1A Proximal stereoscopic view of the first stopper of the syringe.
[0062] Figure 3B yes Figure 3A Distal stereoscopic view of the first stop member.
[0063] Figure 3C yes Figure 3A A cross-sectional view of the first stop member.
[0064] Figure 4A According to one aspect of the present disclosure Figure 1A A stereoscopic view of the second stopper of the syringe.
[0065] Figure 4B Figure 4A A cross-sectional view of the second stop member.
[0066] Figure 5A According to one aspect of the present disclosure Figure 1A A perspective view of a guide member of a syringe.
[0067] Figure 5B yes Figure 5A A cross-sectional view of a guide member.
[0068] Fig. 6A According to one aspect of the present disclosure Figure 1A A stereoscopic view of the barrel of a syringe.
[0069] Figure 6B yes Fig. 6A A cross-sectional view of the distal portion of the barrel.
[0070] Figure 6C yes Fig. 6A A stereoscopic view of the proximal end of the barrel.
[0071] Fig. 7A According to one aspect of the present disclosure Figure 1A A stereoscopic view of the plunger rod of a syringe.
[0072] Figure 7B yes Fig. 7A A stereoscopic view of the distal end of the plunger rod.
[0073] Figure 8 is a flow chart illustrating a method for sequentially expelling fluids from a multi-chamber syringe according to an aspect of the present disclosure.
[0074] Fig. 9A is a cross-sectional view of another example of a multi-chamber syringe in an intermediate position with a filled second chamber and an empty first chamber.
[0075] Fig. 9B The intermediate position is after the first stopper is rotated to establish fluid communication between the second chamber and the first chamber. Fig. 9A Cross-sectional view of a multi-chamber syringe.
[0076] Fig. 9C yes Fig. 9A Cross-sectional view of the first stopper of a syringe.
[0077] Fig.9D yes Fig. 9A Another cross-sectional view of the first stopper of the syringe. DETAILED DESCRIPTION
[0078] The following description is provided to enable those skilled in the art to make and use the described embodiments intended for implementing the present invention. However, various modifications, equivalents, variations and substitutes will still be apparent to those skilled in the art. Any and all such modifications, variations, equivalents and substitutes are intended to fall within the spirit and scope of the present invention.
[0079] Hereinafter, for the purpose of description, the terms "upper", "lower", "right", "left", "vertical", "horizontal", "top", "bottom", "lateral", "longitudinal" and their derivatives shall relate to the present invention as oriented in the accompanying drawings. As used herein, the term "proximal" refers to the portion or end of a device (e.g., a syringe or catheter) that is held, manipulated, or used by a practitioner or another user. The term "distal" refers to the end or portion of a device that is farthest from the portion of the device that is held, manipulated, or used by the practitioner. For example, the "proximal end" of a catheter or IV line refers to the end that includes a fluid port connected to a fluid container (e.g., an IV bag or a syringe). The "distal end" of a catheter or IV line refers to the end that is connected to the patient. However, it should be understood that the present invention may employ alternative variations and alternative step sequences unless expressly stated to the contrary. It should also be understood that the specific devices and processes shown in the drawings and described in the following specification are merely exemplary embodiments of the present invention. Therefore, specific dimensions and other physical features associated with the embodiments disclosed herein should not be considered limiting.
[0080] With reference to the accompanying drawings, the present disclosure relates to a multi-chamber syringe 10, 210 that discharges a first fluid F1 and a subsequent second fluid F2 from a syringe barrel, for example, to a vascular access device, through a fluid port or nozzle of the syringe 10, 210. The first fluid F1 can be a medical fluid, which, as used herein, can refer to a drug, a total parenteral nutrient (TPN) liquid, or another therapeutic agent for treating a chronic or acute disease as known in the art. For example, exemplary therapeutic agents can include drugs, chemicals, biological substances, or biochemical substances that achieve a desired therapeutic effect when delivered to a patient in an amount effective for treatment. The second fluid F2 can be a flushing solution, such as saline and / or a heparin lock flushing solution. An example of a saline flushing solution is 0.9% sodium chloride USP for injection. An example of a heparin lock flush solution is 0.9% sodium chloride with 100 USP units of heparin sodium per milliliter (mL) or 10 USP units of heparin sodium per milliliter. As known in the art, other flush solutions may also be used with the syringes 10, 210 of the present disclosure. The syringes 10, 210 may also be used to sequentially deliver a first drug or therapeutic agent followed by a different second drug or therapeutic agent.
[0081] The syringe 10,210 of the present disclosure allows practitioners (e.g., medical technicians, nurses, physician assistants, physicians or other trained or untrained clinicians or medical care personnel) to apply a flushing solution after applying, for example, a drug, without having to replace the syringe between the first and second fluids. Advantageously, by, for example, advancing the plunger rod of the syringe 10,210, the sequential delivery of the drug and the subsequent flushing solution occurs automatically. As used herein, the "advancement" of the plunger rod means that the practitioner can push the plunger rod in the distal direction through the barrel of the syringe 10,210 as a single stroke to discharge the first fluid and the subsequent second fluid from the syringe barrel. For example, between the delivery of the first fluid and the second fluid, the practitioner does not need to, for example, disconnect the syringe or another device from the VAD. In addition, in order to perform the sequential delivery of the first fluid and the second fluid, using the syringe 10,210 of the present disclosure, the practitioner does not need to change the moving direction of the plunger rod, nor does it need to press another component or mechanism of the syringe 10,210.
[0082] In some examples, the syringe 10, 210 is provided as a partially pre-filled syringe, wherein the chamber of the syringe 10, 210 is filled with a flushing solution during manufacture. The partially pre-filled syringe 10, 210 may include a cap, a clip, a retainer, and / or other packaging to hold the plunger rod in place and to ensure that the flushing solution does not leak from the partially pre-filled syringe 10, 210 at an unexpected time (e.g., during shipping).
[0083] The syringes 10, 210 of the present disclosure are also configured to allow a practitioner to draw a medical fluid into the syringe 10, 210 prior to delivering the fluid to a patient. For example, a practitioner may insert the nozzle or needle of the syringe 10, 210 into a vial containing the medical fluid and then draw the medical fluid into the fluid chamber of the syringe 10, 210 by moving the plunger rod of the syringe 10, 210 in a proximal direction. After the medical fluid is drawn into the fluid chamber of the syringe 10, 210, sequential delivery of a first fluid followed by a second fluid may occur by connecting the syringe 10, 210 to a fluid port of a VAD and then moving the plunger rod of the syringe 10, 210 in a distal direction, thereby expelling the first fluid followed by the second fluid from the syringe 10, 210 to the VAD.
[0084] By eliminating the need to clean or disinfect multiple parts of the VAD between delivering the first fluid and the second fluid, the syringe 10, 210 of the present disclosure simplifies the fluid application procedure and saves a considerable amount of time compared to conventional fluid application practices. The syringe 10, 210 of the present disclosure also reduces the risk of infection and allows the VAD to be flushed immediately after the medical fluid is applied, which can prevent drug blockage in the VAD. In addition, the syringe 10, 210 of the present disclosure has zero dead space, which means that when the second fluid (e.g., flushing solution) moves through the syringe 10, 210 to the VAD, all medical fluid contained in the first chamber of the syringe 10, 210 is flushed out of the syringe 10, 210.
[0085] Multi-chamber syringe for sequential delivery of drugs
[0086] Figures 1A to 2E An example of a multi-chamber syringe 10 is shown, which is used to sequentially discharge at least a first fluid F1 contained in a first chamber 12, followed by a second fluid F2 contained in a second chamber 14. As previously described, the first fluid F1 can be a medical fluid, such as a drug or another therapeutic agent intended to be delivered to a patient through a VAD (e.g., a catheter or IV line). The second fluid F2 can be a flushing solution, such as a saline solution and / or an anticoagulant, such as heparin. The type of flushing solution contained in the second chamber 14 and the amount of the flushing solution can vary depending on, for example, the specific type of catheter or IV line used. In some examples, the syringe 10 contains or is configured to hold about 1 mL to 20 mL of the second fluid F2, or preferably about 5 mL to about 10 mL of the second fluid F2.
[0087] In some examples, the syringe 10 includes a barrel 16 having an open proximal end 18, a distal end 20 including a nozzle or fluid port 22 for discharging a first fluid F1 and a second fluid F2 from the barrel 16, and a sidewall 24 extending between the proximal end 18 and the distal end 20 of the barrel 16. The fluid port 22 of the barrel 16 can be a connector, such as a Luer connector, a threaded connector, or a snap-on connector, which is configured to be connected to a needle for accessing, for example, the interior of a medical vial containing a medical fluid. The fluid port 22 of the syringe 10 can also be configured to be directly or indirectly connected to a fluid port, a valve, or another end access portion of a VAD. For example, a common type of fluid port of a VAD is a pierceable septum or pre-split septum made of rubber or other elastomeric material that allows a sharp or blunted needle cannula to be inserted to infuse fluid into or extract fluid from the catheter of the VAD. Another common fluid port of a VAD is a valve that does not require a needle for accessing the VAD. Instead, the valve can be activated by the frustoconical tip of the syringe barrel 16 to provide fluid communication between the interior of the barrel 16 and the VAD.
[0088] In some examples, as is known in the art, the barrel 16 of the syringe 10 can be substantially similar in shape, size, and construction to the barrel of a syringe for administering a flushing solution to a VAD. For example, the barrel 16 can be a cylindrical structure formed of a rigid thermoplastic material (e.g., polyester, polycarbonate, polypropylene, polyethylene, polyethylene terephthalate, acrylonitrile butadiene styrene, or other injection moldable or formable resin materials known in the art). For example, an exemplary barrel for a flushing syringe is described in U.S. Patent Application Publication No. 2020 / 0061297, entitled “Flush Syringe Assembly with Controlled Pulsatile Flushing,” the entire contents of which are incorporated herein by reference.
[0089] The syringe 10 also includes a distal or first stopper 26 and a proximal or second stopper 28 slidably disposed within the barrel 16 of the syringe 10. The stops 26, 28 divide the barrel 16 into the first chamber 12 and the second chamber 14. Specifically, as shown in FIG. Figure 1A As shown, the distal or first chamber 12 is located between the distal end 20 of the barrel 16 and the distal end of the first stop 26. The proximal or second chamber 14 is located between the proximal end of the first stop 26 and the second stop 28.
[0090] For example, Figure 1A , Figure 1B , Figure 2D , Figure 2Eas well as FIG. 3A to FIG. 3C , the first stopper 26 includes a cutout section or channel 30 that, when properly oriented, allows fluid to flow from the second chamber 14 to the first chamber 12. As described in more detail herein, rotation of the first stopper 26 relative to the syringe barrel 16 properly orients the channel 30 of the first stopper 26, thereby establishing fluid communication between the second chamber 14 and the first chamber 12 through the channel 30 of the first stopper 26.
[0091] As is known in the art, the stops 26, 28 include many features of conventional syringe stops or plungers. For example, the stops 26, 28 can be formed from a thermoplastic elastomeric material (e.g., polypropylene or polyethylene) and from a synthetic rubber or natural rubber (e.g., isoprene). The first stop 26 and / or the second stop 28 can include a proximal surface 32 or proximal end, a distal surface 34 or distal end, and a peripheral surface 36 extending between the proximal surface 32 and the distal surface 34. In some examples, such as Figures 1A to 2E 22, the distal surface 34 or distal end of the stopper may be conical or frusto-conical to assist in expelling fluid from the barrel 16 through the fluid port 22. Alternatively, the distal end or distal surface 34 of the stopper 26, 28 may be substantially flat, as is the second stopper 28. The stopper 26, 28 may also include one or more annular ribs 38 protruding from the outer peripheral surface 36. The annular ribs 38 are configured to seal against the inner surface of the sidewall 24 of the syringe barrel 16, thereby ensuring that the fluid flows through the syringe barrel 16 in an intended manner. In some examples, the stopper 26, 28 includes a plurality of annular ribs 38 to improve stability and prevent the stopper 26, 28 from tilting, shifting, or otherwise deforming as it moves through the syringe barrel 16.
[0092] The stops 26, 28 are configured to move through the syringe barrel 16 to draw fluid into the barrel 16 and to expel fluid from the barrel 16. For example, Figure 2B As shown by arrows P in FIG. 1 , the first stopper 26 and the second stopper 28 move in the proximal direction through the barrel 16 to draw the first fluid F1 into the first chamber 12 through the fluid port 22 of the barrel 16. In a similar manner, as described in more detail below, Figure 2C and Figure 2D As shown by arrows D in FIG. 8 , movement of the first and second stops 26 , 28 in the distal direction through the barrel 16 discharges the first fluid F1 from the first chamber 12 and the second fluid F2 from the second chamber 14 through the fluid port 22 of the barrel 16 .
[0093] More specifically, the stops 26, 28 are configured to move between several positions during a fluid expulsion procedure. The syringe 10 may initially be set in a partially filled position, such as Figure 2A , wherein the second fluid F2 (e.g., flushing solution) is located in the second chamber 14. In this initial or partially filled position, the stoppers 26, 28 are spaced apart from each other by a distance D1 (e.g., Figure 2B ), to accommodate a volume of about 1 mL to 20 mL of the second fluid F2, or preferably a volume of about 5 mL to 10 mL of the second fluid F2. When ready for use, the practitioner can move the first stopper 26 to a distal-most position against the distal end 20 of the barrel 16. Then, as Figure 2B As shown, the practitioner can move the stops 26, 28 in the proximal direction ( Figure 2B ), so as to draw the first fluid F1 into the first chamber 12, thereby completely filling the syringe 10. Figure 2B As shown, when the syringe 10 is filled, the first stop 26 is a distance D2 from the distal end 20 of the barrel 16. Once the syringe 10 is filled, the stops 26, 28 are moved in the distal direction (eg, Figure 2C and Figure 2D The first stopper 26 is moved toward the distal end 20 of the syringe 10 (as shown by the arrow D in FIG. 1 ), thereby discharging the first fluid F1 from the first chamber 12. The syringe 10 is Figure 2C 14 and an empty first chamber 12. Figure 2D As shown by arrow A1 in FIG. 1 , fluid communication between the second chamber 14 and the first chamber 12 is established by rotating the first stopper 26 to properly align the channel 30 of the first stopper 26. Then, the second fluid F2 is discharged from the syringe 10 by moving the second stopper 28 toward the first stopper 26. Specifically, the movement of the second stopper 28 toward the first stopper 26 causes the second fluid F2 to move from the second chamber 14 to the first chamber 12, and then from the syringe barrel 16 through the fluid port 22. Figure 2E The syringe 10 is shown in an end-of-use position after the fluids F1 , F2 have been expelled from the syringe barrel 16. In the end-of-use position, the distal surface 34 of the second stop 28 is in contact or nearly in contact with the proximal surface 32 of the first stop 26.
[0094] Continue to refer Figures 1A to 2E The syringe 10 also includes a plunger rod 40 connected to the second stop 28 for moving the second stop 28 and the first stop 26 through the syringe barrel 16. For example, the plunger rod 40 can be an injection molded component formed of a rigid thermoplastic material (e.g., polyester, polycarbonate, polypropylene, polyethylene, polyethylene terephthalate, or other thermoplastic materials known in the art). The plunger rod 40 includes a distal end 42 that engages the second stop 28. For example, as Figure 7BAs best seen in FIG. 1 , the distal end 42 of the plunger rod 40 may include an annular connector 44 that is inserted into a corresponding annular cavity 46 (eg, Figure 4B The plunger rod 40 may also include a tab 48 (as shown) or a slot on the proximal surface 32 of the second stopper 28. Figure 7B ), the tab 48 extends radially inward from the annular connector 44 to maintain the position of the plunger rod 40 relative to the other structures of the syringe 10. The plunger rod 40 also includes a proximal end 50 protruding proximally from the proximal end 18 of the syringe barrel 16 and a body 52 extending between the proximal end 50 and the distal end 42 of the plunger rod 40. The proximal end 50 of the plunger rod 40 may include a thumb pressure plate 54 for manipulating the plunger rod 40 to move the stoppers 26, 28 through the syringe barrel 16. Within the scope of the present disclosure, the body 52 of the plunger rod 40 may have a variety of cross-sectional shapes and configurations. For example, as Fig. 7A and Figure 7B As shown, the body 52 has a generally cross-shaped cross section. In other examples, the cross section of the plunger rod 40 may be an I-beam, a hollow circle, a hollow square, a hollow rectangle, or an L-shape. Figure 2A As shown, the syringe 10 may also include a removable plunger cap 58 (eg, Figure 2A ), the removable plunger cap is engaged between the thumb depressing plate 54 of the plunger rod 40 and the proximal end 18 of the barrel 16 for preventing movement of the plunger rod 40 until the removable plunger cap 58 is removed from the syringe 10.
[0095] In some examples, the syringe 10 further includes an elongated guide member 60 fixed to the first stop 26 for rotating the first stop 26 relative to the barrel 16. The guide member 60 may be formed of a rigid thermoplastic material, which may be the same material as the barrel 16 and / or the plunger rod 40, or a different material. Figure 5A and Figure 5B As shown, the guide member 60 includes a proximal end 62, a cavity 66 (eg, FIG. 3A to FIG. 3C 6, and a side wall or side surface 68 extending between the proximal end 62 and the distal end 64 of the guide member 60. The guide member 60 may include radially extending locking projections or ridges 70 extending from the distal end 64, which engage with corresponding slots 72 or recesses in the cavity 66 of the first stop 26 to secure the guide member 60 to the first stop 26. FIG. 2A to FIG. 2E As shown, the guide member 60 passes through the second stopper 28. For example, the guide member 60 can pass through the through hole 74 in the second stopper 28 (at Figure 4A and Figure 4B), which allows the second stop 28 to slide along the guide member 60 as the plunger rod 40 moves the second stop 28 in the distal direction through the barrel 16 .
[0096] In some examples, the plunger rod 40 includes an elongated recess 76 that extends axially through at least a portion of the body 52 of the plunger rod 40 from the distal end 42 of the plunger rod 40 toward the proximal end 50 of the plunger rod 40. The elongated recess 76 is sized so that the elongated recess 76 receives the guide member 60 as the second stop 28 moves through the barrel 16 in a distal direction toward the first stop 26. More specifically, once the first stop 26 is in its most distal position (e.g., Figure 2D As shown in FIG. 1 , the practitioner can continue to press the plunger rod 40, thereby moving the second stop 28 in the distal direction. The distal movement of the second stop 28 causes the second stop 28 to slide along the elongated guide member 60, which means that the guide member 60 is received in the elongated recess 76 of the plunger rod 40. Figure 2E 4, the second stop 28 is in its most distal position, in which the second stop 28 contacts or nearly contacts the proximal end or proximal surface 32 of the first stop 26, and the guide member 60 is fully received within the elongated recess 76 of the plunger rod 40. In some examples, the guide member 60 also includes an axially extending slot, locking member, or recess 78 that receives the tab 48 of the plunger rod 40. The engagement between the tab 48 of the plunger rod 40 and the recess 78 of the guide member 60 prevents the plunger rod 40 from rotating about the guide member 60, which means that any rotation of the plunger rod 40 is transmitted to the first stop 26 through the guide member 60.
[0097] As previously described, fluid communication between the second chamber 14 and the first chamber 12 of the syringe 10 is established by rotating the first stopper 26 relative to the syringe barrel 16. Specifically, the practitioner can grasp the plunger rod 40 and rotate the plunger rod 40, which causes the first stopper 26 and the second stopper 28 to rotate relative to the syringe barrel 16. The structure of the first stopper 26 and the syringe barrel 16, which provide fluid communication between the chambers 12, 14 of the syringe 10 through the first stopper 26, will now be described in more detail.
[0098] refer to FIG. 3A to FIG. 3C , the first stopper 26 includes a passage 30 for allowing fluid to pass between the second chamber 14 and the first chamber 12 of the syringe barrel 16. FIG. 3A to FIG. 3CAs shown, the first stopper 26 includes two channels positioned on opposite sides of the first stopper 26 such that the first stopper 26 is vertically symmetrical (i.e., symmetrical through a vertical plane). In other examples, the first stopper 26 may include more than two channels 30, such as channels 30 positioned at 0 degrees, 90 degrees, 180 degrees, and 270 degrees around the perimeter of the first stopper 26. In other examples, the first stopper 26 may include only a single channel 30. The channel 30 includes an inflow portion or inlet 80 for receiving the second fluid F2 from the second chamber 14, and an outflow portion or outlet 82 for discharging the second fluid F2 from the channel 30 into the first chamber 12. As shown in FIG. FIG. 3A to FIG. 3C As shown, the passage 30 is a cutout or recess that extends axially from a proximal end or proximal surface 32 of the first stop 26 and radially inwardly from an outer peripheral surface 36 of the first stop 26 .
[0099] like Figure 3B and Figure 3C As shown, the first stopper 26 may also include a channel or groove 84 on the distal surface 34 of the first stopper 26, which is positioned so that the fluid from the second chamber 14 can pass through the first chamber 12 to the fluid port 22 at the distal end 20 of the syringe barrel 16. For example, the channel or groove 84 can be an elongated recess positioned on the center of the distal surface 34 of the first stopper 26, which is positioned so that the first stopper 26 does not prevent the fluid from entering the fluid port 22 at the distal end 20 of the barrel 16.
[0100] refer to Fig. 6A and Figure 6B , the syringe barrel 16 includes one or more radial extensions or widened portions 86 near the distal end 20 of the barrel 16, which are positioned to allow fluid to flow through the passage 30 of the first stop 26 when the first stop 26 is properly aligned with the widened portion 86 of the barrel 16. As used herein, the widened space or widened portion 86 of the barrel 16 refers to such areas of the barrel 16: in these areas, the radial distance between the inner surface of the side wall 24 of the barrel 16 and the central axis of the barrel 16 is greater than the radial distance between the inner surface of the side wall 24 and the central axis of the barrel 16 in other portions. For example, as Fig. 6A and Figure 6B As shown, the widened space or portion 86 may be an elongated space or axial slot molded into the side wall 24 of the barrel 16 .
[0101] The channel 30 of the first stopper 26 and the widened portion 86 of the barrel 16 are configured to allow fluid to pass from the second chamber 14 into the channel 30 through the inlet 80 of the channel 30. For most radial orientations of the first stopper 26, the outlet 82 of the channel 30 is sealed by the inner surface of the sidewall 24 of the barrel 16, thereby preventing fluid from flowing from the channel 30 to the first chamber 12. When the first stopper 26 is rotated so that the outlet 82 of the channel 30 is located within the widened space or widened portion 86 of the barrel 16, fluid is allowed to flow from the second chamber 14 to the first chamber 12 through the channel 30 of the first stopper 26. Therefore, the rotation of the first stopper 26 relative to the barrel 16 establishes fluid communication between the second chamber 14 and the first chamber 12 through the channel 30.
[0102] like Figure 6B As shown, the barrel 16 includes two widening spaces or widening portions 86, which correspond to the two channels 30 of the first stopper 26. The size of the widening spaces or widening portions 86 generally corresponds to the width of the channels 30 of the first stopper 26, and in particular can be selected to allow fluid to flow through the syringe barrel 16 between the second chamber 14 and the first chamber 12 at a reasonable rate. If the channels 30 or widening portions 86 are too narrow, the fluid may not flow well between the chambers 12, 14 of the barrel 16.
[0103] The arc width of the widened portion 86 of the barrel 16 also affects how far the first stopper 26 must be rotated in order to establish fluid communication between the second chamber 14 and the first chamber 12. If the arc width of the widened portion 86 is too wide, the first stopper 26 may only require a small amount of rotation to establish fluid communication between the chambers 12, 14 of the barrel 16, which may result in accidental activation of the syringe 10 or fluid leakage between the chambers 12, 14. Therefore, in some examples, the syringe 10 is configured such that the first stopper 26 should be rotated about 90 degrees relative to the syringe barrel 16 to properly align the channel 30 and the widened portion 86 to establish fluid communication between the second chamber 14 and the first chamber 12. In this case, the widened portion 86 of the barrel 16 can have an arc width of less than 90 degrees, or, for example, an arc width between about 45 degrees and 70 degrees. The height of the widened portion 86 must be less than the height of the first stop 26 so that fluid flow through the widened portion 86 will only occur when the first stop 26 is rotated to properly align the passage 30 with the widened portion 86 of the syringe barrel 16 .
[0104] In some examples, specific reference is made to Fig. 6A and Figure 6CThe syringe barrel 16 may also include a rotation limiter or rotation limit structure that is configured to engage the plunger rod 40 to prevent the plunger rod 40 from rotating relative to the syringe barrel 16 at an incorrect time. Figure 6C As shown, the barrel 16 may include an elongated groove 88 extending axially along the proximal portion of the sidewall 24 of the barrel 16. The groove 88 is configured to receive a radially extending portion or fin 90 of the plunger rod 40 to prevent the plunger rod 40 from rotating until the first stop 26 is in its most distal position ( FIG. 2C to FIG. 2E ).
[0105] More specifically, if Fig. 7A As shown, the plunger rod 40 includes radially extending fins 90 extending radially outward from a central portion 92 of the plunger rod 40. Near the distal end 42 of the plunger rod 40, the fins 90 extend radially beyond the remainder of the plunger rod 40 so that the fins 90 can be received within the axial grooves 88 near the proximal end 18 of the barrel 16. When the fins 90 are received within the grooves 88, the plunger rod 40 is prevented from rotating relative to the syringe barrel 16. Near the middle of the plunger rod 40, the fins 90 include a tapered portion 94 ( Fig. 7A 16 ), the tapered portion tapers radially inwardly away from the groove 88 of the barrel 16, which means that the portion of the fin 90 between the tapered portion 94 in the middle of the plunger rod 40 and the proximal end 50 of the plunger rod 40 is not received in the groove 88 of the barrel 16. Therefore, when the plunger rod 40 is first pushed into the syringe barrel 16, the fin 90 is received in the groove 88 and engages with the groove 88, thereby preventing the plunger rod 40 from rotating. When the plunger rod 40 is further inserted into the barrel 16, so that the tapered portion 94 of the fin 90 passes through the groove 88, the groove 88 no longer restricts the rotation of the plunger rod 40. Therefore, the plunger rod 40 can rotate freely relative to the barrel 16, which means that the stoppers 26, 28 can rotate to establish fluid communication between the second chamber 14 and the first chamber 12. Method of discharging fluid from a multi-chamber syringe
[0106] As previously described, the syringe 10 is used to sequentially discharge fluid from the syringe 10 into the VAD, such as discharge of a medical fluid followed by discharge of a flushing solution. A flowchart showing the steps of a sequential fluid discharge process using the syringe 10 is provided in Figure 8 Shown in.
[0107] like Figure 8As shown, at step 110, the practitioner initially obtains a partially filled syringe 10, wherein the second chamber 14 of the syringe 10 is filled with a predetermined volume of a second fluid F2, such as a flushing solution. For example, the partially filled syringe 10 can contain about 1 mL to about 20 mL of flushing solution, or preferably about 5 mL to 10 mL of flushing solution. The syringe 10 in the initial or partially filled position is Figure 2A At step 112, the practitioner prepares the syringe 10 for use by, for example, removing any packaging from the syringe 10 and removing the plunger rod cap 58 that holds the plunger rod 40 in place. Figure 2C and Figure 2D , the practitioner may also move the plunger rod 40 in the distal direction so that the first stop 26 of the syringe 10 is completely in its most distal position. At step 114, the practitioner places the syringe barrel 16 in fluid communication with the interior of the container, the interior of the container containing the medical fluid to be delivered to the patient. For example, the practitioner may attach a needle (not shown) to the fluid port 22 at the distal end 20 of the syringe barrel 16 and insert the needle into a container (e.g., a medical vial) containing the medical fluid to be injected into the patient.
[0108] At step 116, the practitioner draws a medical fluid into the first chamber 12 of the barrel 16. For example, Figure 2B As shown by the middle arrow P, the practitioner can grasp the plunger rod 40 and move the plunger rod 40 in the proximal direction, which causes the stoppers 26, 28 to move in the proximal direction, such as Figure 2B As shown by arrow A2 in the figure, fluid is sucked or drawn from the interior of the container into the first chamber 12 of the syringe barrel 16. The syringe 10 is Figure 2B 1 is shown in its fully filled position, with the first fluid F1 being located in the first chamber 12 and the second fluid F2 being located in the second chamber 14 .
[0109] Once a dose of the medical fluid to be delivered to the patient is drawn into the first chamber 12, at step 118, the practitioner removes the needle from the fluid port 22 of the syringe barrel 16 and connects the fluid port 22 to the VAD. For example, the practitioner can insert the nozzle of the syringe barrel 16 into a corresponding port or valve of the VAD, thereby establishing fluid communication between the syringe barrel 16 and the lumen of the VAD. At step 120, once the syringe 10 is properly connected to the VAD, the practitioner grasps the plunger rod 40 and pushes the plunger rod 40 in the distal direction, which causes the stoppers 26, 28 to move distally (e.g., Figure 2C and Figure 2D The distal movement of the first stopper 26 causes the first fluid F1 (eg, medical fluid) in the first chamber 12 of the syringe barrel 16 to be discharged from the syringe barrel 16, as shown by the arrow D in FIG. Figure 2C The practitioner continues to move the plunger rod 40 in the distal direction until the first stop 26 is located in the syringe barrel 16 at its most distal position. Figure 2C is shown in this distal-most position.
[0110] At step 122, with the first stop 26 in its most distal position, the practitioner rotates the first stop 26 (eg, Figure 2D The first stopper 26 is rotated relative to the syringe barrel 16 by a predetermined amount (e.g., about 90 degrees) to properly align the outlet 82 of the passage 30 of the first stopper 26 with the widened portion 86 or space of the syringe barrel 16. As previously described, rotating the first stopper 26 relative to the syringe barrel 16 in this manner establishes fluid communication between the second chamber 14 of the syringe barrel 16 and the first chamber 12, as shown in FIG. Figure 2D As shown by arrow A4 in FIG.
[0111] At step 124, once fluid communication is established between the second chamber 14 and the first chamber 12, the practitioner continues to push the plunger rod 40 in the distal direction, which moves the second stopper 28 through the syringe barrel 16 in the distal direction toward the proximal surface 32 of the first stopper 26. The movement of the second stopper 28 toward the first stopper 26 causes the second fluid F2 (e.g., flushing solution) in the second chamber 14 to enter the channel 30 of the first stopper 26 and enter the first chamber 12. The second fluid F2 then passes through the first chamber 12 and is discharged from the syringe barrel 16 to the VAD through the fluid port 22 at the distal end 20 of the syringe barrel 16. The syringe 10 is in the Figure 2E 2 is shown in an end-of-use or final position, wherein the distal surface 34 of the first stop 26 contacts or nearly contacts the proximal surface 32 of the first stop 26 .
[0112] Multi-chamber syringe including a stopper having a closed fluid passage
[0113] 9A to 9D Another example of a multi-chamber syringe 210 is shown for sequentially delivering a first fluid F1 (eg, a medical fluid) and subsequently a second fluid F2 (eg, a flushing solution). The syringe 210 includes Figures 1A to 2E2. The syringe 210 of claim 10 has many components and features of the syringe 10 shown in FIG. In particular, the syringe 210 includes a barrel 216 having an open proximal end 218, a distal end 220 including a fluid port, and a sidewall 224 extending between the proximal end 218 and the distal end 220 of the barrel 216. The syringe 210 also includes a first stopper 226 and a second stopper 228 slidably positioned in the barrel 216. The stops 226, 228 divide the barrel 216 into chambers 212, 214. Specifically, the syringe 210 includes a first chamber 212 located between the distal end 220 of the barrel 216 and a distal surface 234 of the first stopper 226, and a second chamber 214 located between a proximal surface 232 of the first stopper 226 and the second stopper 228.
[0114] As in the previous examples, the syringe 210 also includes a plunger rod 240 connected to the second stop 228 for moving the second stop 228 and / or the first stop 226 through the barrel 216. The syringe 210 also includes a guide member 260 fixed to the first stop 226 for rotating the first stop 226 relative to the barrel 216. As in the previous examples, rotation of the plunger rod 240 causes the guide member 260 to rotate, which in turn causes rotation of the first stop 226. Also as in the previous examples, the plunger rod 240 includes an elongated recess 276 that receives the guide member 260 when the second stop 228 moves in the distal direction toward the first stop 226.
[0115] As in the previous examples, the first stopper 226 includes a channel 230 for establishing fluid communication between the second chamber 214 and the first chamber 212. Specifically, rotation of the first stopper 226 relative to the syringe barrel 216 establishes fluid communication between the second chamber 214 and the first chamber 212 through the channel 230 of the first stopper 226. The syringe 210 differs from the previous examples in the structure of the channel 230. Specifically, unlike the cutout portion or recess of the previous examples, the channel 230 of the first stopper 226 is a closed passage 296 that extends from an inlet 280 on the proximal surface 232 of the first stopper 226 to an outlet 282 on the outer surface 236 of the first stopper 226. 9A to 9D As shown, the first stop 226 includes two closed passages 296 located on opposite sides of the first stop 226, such that the first stop 226 is vertically symmetrical. In other examples, the first stop 226 may include only a single closed passage 296 or more than two closed passages 296. For example, the first stop 226 may include closed passages 296 located at 0 degrees, 90 degrees, 180 degrees, and 270 degrees around the perimeter of the first stop 226 or at any other convenient location on the first stop 226.
[0116] The syringe 210 operates in the same manner as in the previous examples. Specifically, once the syringe 210 is filled with the first fluid F1 in the first chamber 212 and the second fluid F2 in the second chamber 214, the fluids F1, F2 are expelled from the syringe 210 by moving the plunger rod 240 in the distal direction. The distal movement of the plunger rod 240 causes the first stop 226 and the second stop 228 to move distally through the syringe barrel 216. As in the previous examples, the first fluid F1 is expelled from the first chamber 212 through the fluid port 222 of the barrel 216 until the first stop 226 is located in its most distal position against the distal end 220 of the barrel 216, as shown in FIG. Fig. 9A Next, as in the previous example, the practitioner rotates the plunger rod 240, as shown. Fig. 9B This causes the outlet 282 of the passage 230 to move into the widened portion 286 of the barrel 216 , thereby establishing fluid communication between the second chamber 214 and the first chamber 212 .
[0117] Once the outlet 282 is located in the widened portion 286 of the barrel 216, the second fluid F2 is able to move through the passage 230 (eg, Fig. 9C and Fig.9D 26) to the first chamber 212. Continued distal movement of the plunger rod 240 causes the second stopper 228 to move along the guide member 260 toward the first stopper 226, which allows the second fluid F2 to enter the first chamber 212 from the second chamber 214 through the channel 230 and then from the barrel 216 through the fluid port 222. Thus, the syringe 210 provides sequential discharge of the first fluid F1 and subsequently the second fluid F2 through a single continuous movement of the plunger rod 240 in the distal direction.
[0118] Although examples of the multi-chamber syringe and method of the present disclosure are shown in the drawings and described in detail above, other examples will be apparent to and easily made by those skilled in the art without departing from the scope and spirit of the present invention. Therefore, the above description is intended to be illustrative rather than restrictive. The invention described above is defined by the appended claims, and all changes to the invention that fall within the equivalent meanings and equivalent ranges of the claims will be included within the scope of the claims.
Claims
1. A multi-chamber syringe for sequentially discharging at least a first fluid and subsequently a second fluid, the syringe comprising: a barrel comprising a proximal end, a distal end, and a sidewall extending between the proximal end and the distal end of the barrel, the distal end comprising a fluid port for expelling the first fluid and the second fluid from the barrel; a first stopper, the first stopper comprising at least one channel, the first stopper being slidably positionable in the barrel, wherein there is a first chamber between the distal end of the barrel and the first stopper, the first chamber being configured to contain the first fluid; as well as a second stopper slidably positioned in the barrel proximate to the first stopper, wherein a second chamber is provided between the first stopper and the second stopper, the second chamber being configured to contain the second fluid, wherein rotation of the first stop relative to the barrel of the syringe establishes fluid communication between the second chamber and the first chamber through the at least one channel of the first stop.
2. The syringe according to claim 1, wherein: Movement of the first stop and the second stop in a proximal direction through the barrel causes fluid to be drawn into the first chamber through the fluid port of the barrel.
3. The syringe according to claim 1, wherein: In a fill position in which the first fluid is in the first chamber and the second fluid is in the second chamber, the first stopper is spaced apart from the second stopper and the second chamber is not in fluid communication with the first chamber, and Wherein, advancing the first stop and the second stop in a distal direction from the filling position to an intermediate position through the barrel discharges the first fluid from the first chamber through the fluid port of the barrel.
4. The syringe according to claim 3, wherein: In the intermediate position, the first stopper is in a distal-most position within the barrel of the syringe and all or substantially all of the first fluid is expelled from the first chamber, and Wherein, when the stopper is in the middle position, rotating the first stopper establishes fluid communication between the second chamber and the first chamber through the at least one channel of the first stopper.
5. The syringe according to claim 4, wherein: With the second chamber in fluid communication with the first chamber, the second stopper is moved axially through the barrel toward the first stopper to move the second fluid from the second chamber through the at least one channel of the first stopper, the first chamber, and the fluid port of the barrel, thereby expelling the second fluid from the barrel.
6. The syringe according to claim 1, wherein: The barrel comprises at least one widened portion, wherein a radial distance between an inner surface of the side wall of the barrel and a central axis of the barrel in the at least one widened portion is greater than a radial distance between the inner surface of the side wall and the central axis of the barrel in other portions of the barrel.
7. The syringe according to claim 6, wherein: The at least one passage through the first stopper comprises an inlet and an outlet, and wherein fluid flow through the at least one passage occurs only when the outlet of the at least one passage is located in the at least one widened portion of the barrel.
8. The syringe according to claim 1, wherein: The at least one channel of the first stopper includes a first cutout section on one side of the stopper and a second cutout section on a side of the first stopper opposite the first cutout section, such that the first stopper is vertically symmetrical.
9. The syringe according to claim 1, wherein: The at least one channel includes at least one closed passage extending from an inlet on the proximal end of the first stopper to an outlet on the outer peripheral surface of the first stopper.
10. The syringe according to claim 1, wherein: The first stop includes a recessed groove on the distal end of the first stop, the recessed groove being positioned to allow fluid to flow through the first stop to the fluid port of the barrel.
11. The syringe of claim 1 , further comprising at least one guide member fixed to the first stopper for rotating the first stopper relative to the barrel, in, A distal end portion of the at least one guide member is received within the cavity of the first stopper, and wherein the at least one guide member comprises at least one axially extending ridge that engages with the axial slot of the cavity to secure the at least one guide member to the first stop.
12. The syringe according to claim 11, wherein The second stop includes a through hole, and wherein the at least one guide member extends through the through hole, thereby allowing the second stop to slide along the at least one guide member when the second stop moves through the barrel in a distal direction.
13. The syringe of claim 11, further comprising a plunger rod connected to the second stopper for moving the second stopper and / or the first stopper through the barrel.
14. The syringe of claim 13, further comprising a removable plunger cap engaged between the plunger rod and the barrel for preventing movement of the plunger rod until the removable plunger cap is removed from the syringe.
15. The syringe according to claim 13, wherein: The plunger rod includes an elongated recess that receives the at least one guide member as the second stop moves through the barrel in a distal direction toward the first stop.
16. The syringe according to claim 13, wherein: The barrel includes at least one rotation limiter engaged with the plunger rod to prevent rotation of the plunger rod, the stopper, and the at least one guide member unless the first stopper is in a distal-most position in the barrel.
17. A pre-filled flushing syringe, the pre-filled flushing syringe comprising: a barrel comprising a proximal end, a distal end, and a sidewall extending between the proximal end and the distal end of the barrel, the distal end comprising a fluid port for expelling a first fluid and a second fluid from the barrel; a first stopper, the first stopper comprising at least one channel, the first stopper being slidably positionable in the barrel, wherein there is a first chamber between the distal end of the barrel and the first stopper, the first chamber being configured to contain the first fluid; as well as a second stopper slidably positioned in the barrel proximate to the first stopper, wherein a second chamber is provided between the first stopper and the second stopper, the second chamber being configured to contain the second fluid, wherein rotation of the first stop relative to the barrel of the syringe establishes fluid communication between the second chamber and the first chamber through the at least one channel of the first stop; and a predetermined volume of the second fluid disposed in the second chamber of the prefilled syringe, The pre-filled syringe is provided with the first chamber, which is fluidically isolated from the second chamber, so that the predetermined volume of the second fluid is contained in the second chamber of the pre-filled syringe.
18. The prefilled syringe of claim 17, wherein: The second fluid includes saline and / or heparin flush solution.
19. A method for sequentially expelling fluid from a syringe according to claim 1, the method comprising: moving the first stopper and the second stopper of the syringe of claim 1 in a distal direction through the barrel to expel the first fluid from the barrel through the fluid port of the barrel; rotating the first stopper to establish fluid communication between the second chamber and the first chamber; as well as The second stopper is moved through the barrel in the distal direction toward the first stopper to allow the second fluid to flow from the second chamber through the at least one passage of the first stopper, the first chamber, and the fluid port of the barrel.
20. The method according to claim 19, wherein: The syringe is arranged to be partially pre-filled, containing a predetermined volume of the second fluid in the second chamber.
